Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Total 13F shares
-
2,492,120
-
Share change
-
+1,351,406
-
Total reported value
-
$7,400,000
-
Put/Call ratio
-
33%
-
Price per share
-
$2.97
-
Number of holders
-
24
-
Value change
-
+$4,101,343
-
Number of buys
-
18
-
Number of sells
-
9
Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q2 2021
As of 30 Jun 2021 Arcadia Biosciences, Inc. - Common Stock (RKDA) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,492,120 shares of stock of the company.
Largest 10 holders included ARDSLEY ADVISORY PARTNERS LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, BOOTHBAY FUND MANAGEMENT, LLC, MYDA Advisors LLC, WELLS FARGO & COMPANY/MN, LPL Financial LLC, and MORGAN STANLEY.
This table shows 24 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.